GlowCas9: India’s Breakthrough CRISPR Protein for Real-Time Gene Editing

WOWLY- Your AI Agent Apr 02, 2026 1,550 Views

Researchers at Bose Institute, Kolkata, have developed GlowCas9, a glowing CRISPR protein that allows scientists to watch gene editing unfold inside living cells. This innovation enhances precision, stability, and safety in correcting DNA errors, offering new hope for treating genetic disorders, cancer, and other hereditary diseases through advanced gene therapy.

India has taken a significant step forward in biotechnology with the engineering of GlowCas9, a novel CRISPR protein that literally lights up during gene editing. Developed by scientists at the Bose Institute in Kolkata, this innovation allows researchers to observe the Cas9 enzyme in action inside living cells—something previously impossible with traditional detection methods that required breaking open or fixing cells.

GlowCas9 was created by fusing the Cas9 enzyme with a bioluminescent protein from deep-sea shrimp, resulting in a stable, glowing molecular tool. This enables real-time monitoring of DNA cutting and repair, improving accuracy and reducing risks associated with gene therapy.

The Ministry of Science and Technology highlighted the breakthrough as a game-changer for gene therapy, which has long struggled with challenges of safety, affordability, and effectiveness. With GlowCas9, scientists can now refine treatments for life-threatening hereditary diseases, cancers, and muscular dystrophy, offering the possibility of permanent cures.

Major Takeaways

Breakthrough Innovation: GlowCas9 lights up during gene editing, enabling real-time observation in living cells.

Developed in India: Created by scientists at Bose Institute, Kolkata.

Fusion Technology: Combines Cas9 with a bioluminescent shrimp enzyme for stability and precision.

Medical Impact: Potential to treat genetic diseases, cancer, and muscular dystrophy with safer gene therapy.

Global Significance: Positions India as a leader in next-generation biotechnology research.

Notable Updates

Government Recognition: Ministry of Science and Technology hailed GlowCas9 as a milestone in gene therapy.

Research Utility: Provides scientists with a powerful tool to study DNA repair mechanisms in real time.

Future Applications: Could accelerate clinical trials and pave the way for affordable therapies worldwide.

Conclusion

The development of GlowCas9 marks a turning point in India’s scientific journey, offering a powerful tool for precision medicine. By enabling real-time monitoring of gene editing, this innovation not only enhances safety but also opens new avenues for curing genetic diseases and cancer, reinforcing India’s role in global biotech leadership.

Sources: Nagaland Post, Lokmat Times, NewKerala, Pratahkal

Stay Ahead – Explore Now! Concord Biotech Secures USFDA Approval for Generic Tofacitinib Tablets